The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients
Abstract
Objective— Obesity is closely linked to the insulin resistance syndrome (IRS), type 2 diabetes, and cardiovascular disease, the primary cause of morbidity and mortality in these patients. Elevated levels of C-reactive protein (CRP) and interleukin-6 (IL-6), indicating chronic subclinical inflammation, have been associated with features of the IRS and incident cardiovascular disease. Methods and Results— We studied the cross-sectional and longitudinal relation of CRP, IL-6, and tumor necrosis factor-α (TNF-α) with features of the IRS in 37 morbidly obese patients with different stages of glucose tolerance before and 14 months after gastric surgery. Weight loss after gastric surgery induced a significant shift from diabetes (37% vs 3%) to impaired glucose tolerance (40% vs 33%) and normal glucose tolerance (23% vs 64%). The baseline concentration of IL-6 was correlated with TNF-α ( r =0.59, P <0.01) and CRP ( r =0.44, P <0.05) levels. TNF-α, IL-6, and CRP were significantly correlated with insulin resistance estimated by the homeostatic model assessment ( r =0.48, P <0.05; r =0.56, P <0.01; and r =0.35, P <0.05, respectively). Concentrations of CRP and IL-6 decreased after weight loss (median, 8.6 and interquartile range, 2.7/14.5 vs 2.5 and 1.2/4.1 mg/L; P <0.006, and 5.13 and 2.72/12.15 vs 3.95 and 1.97/5.64 pg/mL, P <0.02, respectively), whereas serum levels of TNF-α remained unchanged (8.6 and 6.3/18.8 vs 11.7 and 5.8/17.2 pg/mL; NS.). Multiple regression analysis revealed that the decrease in insulin resistance remained independently and significantly correlated with the decrease in IL-6 concentrations ( P <0.01) and the decrease in body mass index with the decrease in CRP ( P <0.05), respectively. Conclusions— Weight loss in morbidly obese patients induces a significant decrease of CRP and IL-6 concentrations in association with an improvement of the IRS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most tests of Fe status, however, are affected in response to subclinical inflammation and infections (690 -692) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [692]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,453
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,366
Self-citationSubcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,032
Research works printed but not linked: 15
- 1982, Am Physiol, 243, E15
- 1999, Diabetes Care, 22, C14
- 1998, J Clin Endocrinol Metab, 83, 847
- 10.1161/circ.101.15.1767 · DOI
- 10.1161/circ.102.1.42 · DOI
- 2001, Circulation, 103, 1913
- 10.1161/atvb.19.4.972 · DOI
- 10.1161/atvb.21.6.961 · DOI
- 2000, J Clin Endocrinol Metab, 85, 3338
- 10.1161/atvb.21.6.968 · DOI
- 10.1161/circ.105.5.564 · DOI
- 1997, J Clin Endocrinol Metab, 82, 4196
- 10.1210/jcem.86.9.7873 · DOI · Paper page
- 10.1161/circ.100.3.230 · DOI
- 10.1161/circ.100.8.793 · DOI
Cited by
Sorted by citations
Items 401–425 of 425
Boyacı, İ., Yiğitbaşı, T., & Ankaralı, H. Ç. (2021) · Medical Science and Discovery · doi:10.36472/msd.v8i4.524
“CRP that is an acute phase indicator, correlate with metabolic syndrome components (35).”
BackgroundMorshed, G., & Fathy, S. M. (2013) · Ain Shams Journal of Surgery · doi:10.21608/asjs.2013.179278
Diabetesremission durch metabolische Chirurgie
Schernthaner, G.-H., Kopp, H.-P., Brix, J., & Schernthaner, G.-H. (2010) · Der Diabetologe · doi:10.1007/s11428-010-0623-6
Self-citationOxidative Stress in Metabolic Disorders/Diseases
Bansal, M., & Kaushal, N. (2014) · Springer eBooks · doi:10.1007/978-81-322-2032-9_3 · Cited by 1
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4_7
ARBEENY, C. M. (2012) · Chemical biology · doi:10.1002/9781118435762.ch21
Шрамко, В. С., Stryukova, E. V., Polonskaya, Y. V., Stakhneva, E. M., Ragino, Y. I., & Kashtanova, E. V. (2022) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20222507159
Renin Angiotensin System and Obesity-Related Organ Damage
Galcerán, I., & Oliveras, A. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-14952-8_16
The Prevalence of Obstructive Sleep Apnea in Bariatric Surgery Patients
Annakkaya, A. N., Balbay, E. G., Pehli̇van, M., & Balbay, Ö. (2023) · Konuralp Tıp Dergisi · doi:10.18521/ktd.1291510
Lee, K. (2022) · Journal of Complementary Medicine & Alternative Healthcare · doi:10.19080/jcmah.2022.11.555816
Goodarzi, S., Shafiee, A., Rafiei, M. A., Dehbozorgi, M., Mofidi, A., Mirzaei, A., Mirzaei, S., & Soltanattar, A. (2025) · Obesity Surgery · doi:10.1007/s11695-025-07952-z
“Reductions in pro-inflammatory markers, including C-reactive protein (CRP) and interleukin-6 (IL-6), further support these effects [60].”
(2014) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/4.3.123-130
de Almeida, C. D. G., Viana, E. C., Moreira, A. V. B., Miguel, G. P. S., Pedra, F. S. G., Oliveira, F. E., Quimquim, T. N., Bissoli, N. S., Alves, R. D. M., & Bressan, J. (2020) · Figshare · doi:10.6084/m9.figshare.11992167
Youssef, H. A. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Age-reversed weight-mortality links in diabetes or prediabetes: evidence from NHANES
Zhang, Z., Gu, P., Yang, W., Wen, Y., Lei, P., Hao, T., Man, C., Niu, W., & Zhu, G. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01896-6
Jackson, E. A., Karvonen-Gutierrez, C. A., Brooks, M. M., Strotmeyer, E. S., Lange‐Maia, B. S., Solomon, D. H., Hood, M. M., & Derby, C. A. (2026) · The Journals of Gerontology Series A · doi:10.1093/gerona/glag058
Hamouda, H. O. (2015) · theses.fr (ABES) · doi:10.70675/50f93b3ez0942z4f48z890dzc84fea4bd38a
Xiao, Y., Zhang, X., Wang, J., Ma, X. H., Sun, B., Li, Y., Chen, L., Guo, Y., Li, X., Guo, H., et al. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s588278
Kaur, K., Awasthy, A. K., Takkar, A., Kaur, P., Kumar, A., Karthik, V. M., Tigari, B., Ahuja, C. K., Saikia, B., Singh, R., et al. (2026) · Brain Research · doi:10.1016/j.brainres.2026.150392
Johansson, H.-E. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
de Jonge, C. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140905cj
(2006) · PubMed · Cited by 56
Metadata
- Authors
- Kopp, H. P., Kopp, C. W., Festa, A., Krzyzanowska, K., Kriwanek, S., Minar, E., Roka, R., & Schernthaner, G.
- Affiliations
- Vienna General Hospital (AT)
- From the Department of Medicine 1 (H.P.K., A.F., K.K., G.S.), Rudolfstiftung Hospital; the Department of Medicine 2 (C.W.K., E.M.), General Hospital of Vienna; and the Department of Surgery 1 and Ludwig Boltzmann Institute for Endocrine Surgery (S.K., R.K.), Rudolfstiftung Hospital, Vienna, Austria.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2003-06
- Volume
- 23
- Issue
- 6
- Pages
- 1042-1047
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2102170193
- Cited by
- 427
- References
- 45
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 10 · 2023: 14 · 2022: 9 · 2021: 10 · 2020: 10 · 2019: 13 · 2018: 17 · 2017: 10 · 2016: 6 · 2015: 24 · 2014: 24 · 2013: 25 · 2012: 15
- FWCI
- 20.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Universität Wien
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- morbid obesity, weight loss, metabolic syndrome, C-reactive protein, interleukin-6, TNF-α, chronic inflammation, gastric bypass, bariatric surgery, impaired glucose tolerance, type 2 diabetes, HOMA, body mass index, glucose tolerance, cardiovascular risk factors, adipokines, adipose tissue inflammation, hepatic insulin resistance
- MeSH terms
- Adult, Blood Glucose, C-Reactive Protein, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Fibrinogen, Humans, Inflammation, Insulin, Insulin Resistance, Lipids, Longitudinal Studies, Male, Middle Aged, Obesity, Morbid, Tumor Necrosis Factor-alpha, Gastroplasty, Weight Loss, Interleukin-6, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
